Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome-Reference-Cited by-同舟云学术

Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome

Published:2019-12 Issue:12 Volume:30 Page:1879-1886
ISSN:1051-0443
Container-title:Journal of Vascular and Interventional Radiology
language:en
Short-container-title:Journal of Vascular and Interventional Radiology

Author:

Liu Dan,Liu Ming,Su Liya,Wang Yu,Zhang Xiaoer,Long Haiyi,Kuang Ming,Xie Xiaoyan,Lin Manxia

Funder

Science and Technology Development Special Fund of Guangdong Province

National Natural Science Foundation Key Program

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Reference29 articles.

1. European Association for the Study of the Liver EASL clinical practice guidelines: management of hepatocellular carcinoma;J Hepatol,2018

2. Efficacy of repeat hepatic resection for recurrent hepatocellular carcinomas;Nagano;ANZ J Surg,2009

3. Repeat liver resection for hepatocellular carcinoma;Nakajima;J Am Coll Surg,2001

4. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study;Peng;Eur Radiol,2018

5. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases;Tateishi;Cancer,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Infectious Complications after Percutaneous Thermal Ablation of Liver Malignancies: A 12-year Single-Center Experience;Radiology;2023-08-01

2. Intelligent Algorithm-Based Ultrasound Images in Evaluation of Therapeutic Effects of Radiofrequency Ablation for Liver Tumor and Analysis on Risk Factors of Postoperative Infection;Contrast Media & Molecular Imaging;2022-09-30

3. Efficacy and safety of camrelizumab plus transarterial chemoembolization in intermediate to advanced hepatocellular carcinoma patients: A prospective, multi-center, real-world study;Frontiers in Oncology;2022-08-02

4. Neoadjuvant Therapy for Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2022-08

5. Liver Cancer: Interdisciplinary Approach;Interdisciplinary Cancer Research;2022